These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 35105823)

  • 21. New approaches to the treatment of biofilm-related infections.
    Wilkins M; Hall-Stoodley L; Allan RN; Faust SN
    J Infect; 2014 Nov; 69 Suppl 1():S47-52. PubMed ID: 25240819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?
    Zhang L; Liang E; Cheng Y; Mahmood T; Ge F; Zhou K; Bao M; Lv L; Li L; Yi J; Lu C; Tan Y
    Biomed Pharmacother; 2020 Aug; 128():110184. PubMed ID: 32450528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.
    Strempel N; Strehmel J; Overhage J
    Curr Pharm Des; 2015; 21(1):67-84. PubMed ID: 25189860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2010; 69(3):125-38. PubMed ID: 21434589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
    Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M
    Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic resistance: a "dark side" of biofilm‑associated chronic infections.
    Marcinkiewicz J; Strus M; Pasich E
    Pol Arch Med Wewn; 2013; 123(6):309-13. PubMed ID: 23828150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies.
    Rather MA; Gupta K; Mandal M
    Braz J Microbiol; 2021 Dec; 52(4):1701-1718. PubMed ID: 34558029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Perspectives in Biofilm Eradication.
    Wolfmeier H; Pletzer D; Mansour SC; Hancock REW
    ACS Infect Dis; 2018 Feb; 4(2):93-106. PubMed ID: 29280609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antibacterials on biofilms.
    Aslam S
    Am J Infect Control; 2008 Dec; 36(10):S175.e9-11. PubMed ID: 19084156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance of bacterial biofilms.
    Høiby N; Bjarnsholt T; Givskov M; Molin S; Ciofu O
    Int J Antimicrob Agents; 2010 Apr; 35(4):322-32. PubMed ID: 20149602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview of Biofilm Formation-Combating Strategies and Mechanisms of Action of Antibiofilm Agents.
    Asma ST; Imre K; Morar A; Herman V; Acaroz U; Mukhtar H; Arslan-Acaroz D; Shah SRA; Gerlach R
    Life (Basel); 2022 Jul; 12(8):. PubMed ID: 35892912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A growing battlefield in the war against biofilm-induced antimicrobial resistance: insights from reviews on antibiotic resistance.
    Pai L; Patil S; Liu S; Wen F
    Front Cell Infect Microbiol; 2023; 13():1327069. PubMed ID: 38188636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections.
    Xu Q; Hu X; Wang Y
    Mol Biotechnol; 2021 Dec; 63(12):1103-1124. PubMed ID: 34309796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies.
    Taylor PK; Yeung AT; Hancock RE
    J Biotechnol; 2014 Dec; 191():121-30. PubMed ID: 25240440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.
    Lebeaux D; Ghigo JM; Beloin C
    Microbiol Mol Biol Rev; 2014 Sep; 78(3):510-43. PubMed ID: 25184564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
    Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
    J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.